OLMA
Olema·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
EPS Beats Expectation
RSI Overbought
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OLMA
Olema Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company that developing targeted therapies for women's cancers
780 Brannan Street, San Francisco, California 94103
--
Olema Pharmaceuticals, Inc., located in San Francisco, California, was incorporated in Delaware on August 7, 2006. The company is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation targeted therapies for women's cancers.
Company Financials
EPS
OLMA has released its 2025 Q3 earnings. EPS was reported at -0.49, versus the expected -0.45, missing expectations. The chart below visualizes how OLMA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
